Barclays set a CHF 365 price objective on Roche Holding Ltd. Genussscheine (VTX:ROG) in a research note released on Thursday, Borsen Zeitung reports. The brokerage currently has a buy rating on the healthcare company’s stock.
Several other research firms have also issued reports on ROG. Deutsche Bank set a CHF 350 target price on shares of Roche Holding Ltd. Genussscheine and gave the stock a buy rating in a research note on Thursday, January 9th. Goldman Sachs Group set a CHF 330 target price on shares of Roche Holding Ltd. Genussscheine and gave the company a buy rating in a report on Monday, November 11th. UBS Group set a CHF 350 price target on shares of Roche Holding Ltd. Genussscheine and gave the company a buy rating in a research report on Friday, January 10th. HSBC set a CHF 225 price target on shares of Roche Holding Ltd. Genussscheine and gave the stock a sell rating in a report on Wednesday, November 27th. Finally, JPMorgan Chase & Co. set a CHF 375 price objective on shares of Roche Holding Ltd. Genussscheine and gave the stock a buy rating in a research report on Wednesday, January 8th. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and eight have given a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average price target of CHF 321.50.
Roche Holding Ltd. Genussscheine has a 52 week low of CHF 214.30 and a 52 week high of CHF 273.
Rogers Corporation designs, develops, manufactures, and sells engineered materials and components worldwide. The company's Advanced Connectivity Solutions segment offers circuit materials and solutions for connectivity applications in wireless communications infrastructure, automotive, connected devices, wired infrastructure, consumer electronics, and aerospace/defense.
Read More: Guidelines for Successful Channel Trading
Receive News & Ratings for Roche Holding Ltd. Genussscheine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. Genussscheine and related companies with MarketBeat.com's FREE daily email newsletter.